| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |